跳至主要内容
临床试验/NCT01547429
NCT01547429暂停不适用

Artisan Aphakia Lens for the Correction of Aphakia in Adults

Ophtec USA35 个研究点 分布在 2 个国家目标入组 300 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
300
试验地点
35
主要终点
Improvement in best corrected visual acuity

研究概览

简要总结

This study will determine the safety and effectiveness of the Artisan Aphakia Lens when used as a secondary implant to correct aphakia in adults.

详细描述

Not desired

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 22 years of age and over at baseline visit of either sex and of any race where the natural lens has been removed or will be removed and a posterior chamber IOL is not indicated.
  • Patient must agree to comply with the visit schedule and other requirements of the study

排除标准

  • Patients that are not able to meet the extensive postoperative evaluation requirements
  • Mentally retarded patients
  • When the patient has no useful vision or vision potential in the fellow eye
  • History of corneal disease (e.g., herpes simplex, herpes zoster keratitis, etc.), corneal dystrophy, degeneration, opacities or abnormalities that may affect vision.
  • Abnormality of the iris or ocular structure which would preclude fixation, such as aniridia, hemiiridectomy, severe iris atrophy, rubeosis iridis, or other compromising iris pathology
  • Patients with uncontrolled glaucoma
  • High preoperative intraocular pressure, >25 mmHg
  • Chronic or recurrent uveitis or history of the same
  • Preexisting macular pathology that may complicate the ability to assess the benefit or lack of benefit obtained by the lens
  • Patients with a retinal detachment or a family history of retinal detachment
  • Retinal disease that may limit the visual potential of the eye such as retinopathy of prematurity or Stargardt's retinopathy Optic nerve disease that may limit the visual potential of the eye
  • Diabetes mellitus
  • Pregnant, lactating, or plans to become pregnant during the course of this study

结局指标

主要结局

Improvement in best corrected visual acuity

时间窗: 3 year follow up

次要结局

未报告次要终点

研究者

发起方
Ophtec USA
申办方类型
Industry
责任方
Sponsor

研究点 (35)

Loading locations...

相似试验